Improving endpoints for sickle cell disease clinical trials: retaining consistency and clinical benefit

Expert Review of Hematology 2026

View at publisher
Authors: Slimane Allali, Martina Bevacqua, Mariane de Montalembert
DOI: 10.1080/17474086.2026.2634282
Cited by: 0
References: 15

Abstract

1. Sickle cell disease (SCD) is a common hemoglobin disorder characterized by chronic hemolytic anemia and severe acute vaso-occlusive events leading to multiple organ damage. It is responsible for...

Fields of Study & Subjects

Hemoglobinopathies and Related Disorders Statistical Methods in Clinical Trials Hemophilia Treatment and Research

Publication details

Journal / source
Expert Review of Hematology
Volume
19
Issue
4
Pages
357–359
Publication date
17 February 2026
Language
EN